ScreenPoint Medical

“It’s invaluable to have a system that doesn’t tire and can consistently assist in identifying even subtle abnormalities.”

“It’s about adding tangible value to the equation. For practices facing declining reimbursements and rising costs, the cost-benefit analysis must be clear.”

“The strongest testimonial comes from peers with similar workflows,”

“By allocating our energy and time more effectively, we can improve both efficiency and the quality of care,”

“What appealed to me was how Transpara helps tackle eye fatigue, overall fatigue, and burnout by enabling us to do more with less. We are able to stratify studies and spend time on the studies that need it, because we save time on other studies,”

“AI isn’t about replacing radiologists; it’s about enhancing our capabilities. With tools like Transpara, we can provide better care for our patients and sustain the well-being of our radiologists. It’s a win-win.”

““Ultimately, AI is like the internet, you’re not going to get rid of it. The main thing is for radiologists to learn to be comfortable with the entire concept of AI – it has never been about replacing radiologists. The only radiologists who should be concerned about getting replaced are the ones who do not use AI to improve cancer detection and patient care.””

““Once it was deployed at all of our sites, the Transpara team collaborated with us on training and ramp up and within six weeks or so, I saw a growing confidence with the system across the entire team.””

““When our radiologists, particularly the general radiologists who read mammograms, review a mammogram of a dense breast that Transpara has marked as low risk, they feel much more comfortable and confident in the decision- making process to not recall that patient.””

““I chose Transpara, not only because of the strength of its published data , but also all of the company’s dedication to technical and business support designed to ensure our success,””

““Ultimately, the Transpara Breast AI helps speed up the identification of normal cases and provides greater confidence,””

““With Transpara, we have realized time savings, in part because the negative predictive value is so high. It really helps get through normal mammograms faster. At the same time, for more difficult cases, it is helpful to have potentially suspicious findings highlighted to give those areas that might have been overlooked, more scrutiny.””

“it's very critical that we have the necessary results in a timely fashion, otherwise we will not have the clinical users adopt this as part of their structured workflow. Sometimes we have patients waiting to do an ultrasound and we could not afford to waste any time whatsoever.”

“now that we have everyone on board and have built that trust, we'll keep on pushing forward.”

“We had a great implementation by our project manager and it's obviously a team effort, not just from the clinical department but also from the implementation from both ScreenPoint and our institution’s side. We managed to get some interviews with all the clinical staff that were interacting with the software through questionnaires and we managed to extract some key KPIs in terms of user adoption on how the radiologists were happy or not with the performance of the algorithms and how easy was it to be used and to report any changes. So, it was very good.”

“we wanted to not only have a good software that would perform well to help the radiologist, but also one which would allow us to be more homogeneous in the way we provide care and maintaining the highest quality across the entire service. In CUF, we have several units and AI offered us a way to ensure a very high and consistent delivery of quality care across each unit.”

“One of the great strengths of Transpara is the high negative predictive value of Low Risk results. When a finding is classified as Low Risk, we can have a high degree of confidence that the exam is negative. This has been confirmed both in the published scientific literature and through our own internal audit across our population.”